0001690279-22-000001.txt : 20220103 0001690279-22-000001.hdr.sgml : 20220103 20220103162834 ACCESSION NUMBER: 0001690279-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 EFFECTIVENESS DATE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nacuity Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001690279 IRS NUMBER: 813011847 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-394011 FILM NUMBER: 22502496 BUSINESS ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-336-3000 MAIL ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 D/A 1 primary_doc.xml X0708 D/A LIVE 0001690279 Nacuity Pharmaceuticals, Inc. FORT WORTH CLUB BLDG. 306 W. 7TH STREET, SUITE 310 FORT WORTH TX TEXAS 76102 817-336-3000 DELAWARE None None Corporation true Halden Conner 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Director President and Chief Executive Officer David Wohlberg 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Director Secretary Gerald Cagle 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Robin Steel 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Benjamin Yerxa 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Charles Lieser 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Chief Financial Officer Robert Ruffolo 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Biotechnology Decline to Disclose 06b true 0001690279-21-000003 2021-03-16 false true true true true Units comprised of Convertible Preferred Shares plus Common Stock Purchase Warrants; Common Stock issued for Warrant conversion; Convertible Preferred Shares issued for exchange of Common Stock false 10000 Maxim Group LLC 120708 Clifford Adam Teller 4631188 405 Lexington Avenue New York NY NEW YORK 10174 All States false 17400000 11626000 5774000 false 144 1444673 0 Commissions include warrants to purchase 716,949 shares of Common Stock at an exercise price of $0.01 per share. 0 false Nacuity Pharmaceuticals, Inc. /s/ Halden Conner Halden Conner President and Chief Executive Officer 2022-01-03